CD2AP

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA003267

Antibody HPA003326

Antibody CAB004352

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A majority of malignant tissues displayed moderate to strong cytoplasmic and membranous immunoreactivity. Malignant gliomas were negative. Malignant cells showed moderate cytoplasmic immunoreactivity. Embryonal carcinoma, endometrial and gastric cancers were strongly stained. Malignant gliomas were weakly stained or negative. Most malignant cells displayed weak to moderate cytoplasmic immunoreactivity. Strong positivity was observed in a majority of pancreatic and gastric cancer as well as several cases of colorectal, breast, prostate, ovarian and urothelial cancers. Several cases of malignant gliomas, malignant melanomas, liver and renal cancers were negative.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected